State Street Corp ownership in ER4 / Emergent BioSolutions Inc.

Emergent BioSolutions Inc.

DE ˙ DB ˙ US29089Q1058

6,70 € ↓ -0,51 (-7,07%)

2026-06-03
AKTIENPREIS

Security	DE:ER4 / Emergent BioSolutions Inc.
Institution	State Street Corp
Latest Disclosed Ownership	2,696,375 shares
Ownership	5.10%

2026-02-09 - State Street Corp has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,696,375 shares of Emergent BioSolutions Inc. (DE:ER4). This represents 5.1 percent ownership of the company. In their previous filing dated 2024-01-23 , State Street Corp had reported owning 1,062,951 shares, indicating an increase of 153.67 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-02-09	2026-02-09	13G	1,062,951	2,696,375	153.67	5.10	148.78
2024-01-23	2024-01-23	13G/A	1,131,955	1,062,951	-6.10	2.05	-5.96
2023-10-10	2023-10-10	13G/A	5,817,955	1,131,955	-80.54	2.18	-81.30
2023-01-10	2023-01-10	13G/A	3,032,727	5,817,955	91.84	11.66	106.74
2022-02-10	2022-02-10	13G		3,032,727		5.64

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,849,701	153,326	5.69	23,653	-29.03	0.0008
2026-02-13	2025-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,696,375	250,616	10.25	33,327	54.50	0.0011
2025-11-14	2025-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,445,759	705,004	40.50	21,572	94.23	0.0007
2025-08-14	2025-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,740,755	30,006	1.75	11,106	33.58	0.0004
2025-05-15	2025-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,710,749	-253,015	-12.88	8,314	-55.71	0.0003
2025-02-14	2024-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,963,764	52,437	2.74	18,774	17.63	0.0007
2024-11-14	2024-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,911,327	1,713,200	864.70	15,960	1,081.27	0.0006
2024-08-14	2024-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	198,127	-859,466	-81.27	1,351	-49.50	0.0001
2024-05-15	2024-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,057,593	-5,358	-0.50	2,676	4.86	0.0001
2024-02-14	2023-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,062,951	-69,004	-6.10	2,551	-33.71	0.0001
2023-11-14	2023-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,131,955	-5,662,189	-83.34	3,849	-92.29	0.0002
2023-08-14	2023-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	6,794,144	1,388,594	25.69	49,937	-10.83	0.0026
2023-05-15	2023-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	5,405,550	-412,405	-7.09	56,001	-18.50	0.0032
2023-05-15	2022-12-31	13F/A-99	EMERGENT BIOSOLUTIONS	COM	29089Q105	5,817,955	1,501,645	34.79	68,710	-24.16	0.0040
2023-05-15	2022-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	5,817,955	1,501,645		68,710		0.0040
2022-11-15	2022-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	4,316,310	165,678	3.99	90,599	-29.68	0.0057
2022-08-15	2022-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	4,150,632	681,162	19.63	128,836	-9.56	0.0077
2022-05-16	2022-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	3,469,470	436,743	14.40	142,456	8.06	0.0070
2022-02-14	2021-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	3,032,727	628,137	26.12	131,833	9.50	0.0063
2021-11-15	2021-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,404,590	273,127	12.81	120,398	-10.33	0.0064
2021-08-16	2021-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,131,463	217,984	11.39	134,261	-24.48	0.0071
2021-07-09	2021-03-31	13F/A-1	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,913,479	-232,112	-10.82	177,781	-7.52	0.0102
2021-05-17	2021-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,913,479	-232,112		177,781		0.0102
2021-02-16	2020-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,145,591	283,423	15.22	192,245	-0.09	0.0118
2020-11-10	2020-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,862,168	-360,542	-16.22	192,418	9.47	0.0131
2020-08-14	2020-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,222,710	47,929	2.20	175,772	39.69	0.0128
2020-06-19	2020-03-31	13F/A-1	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,174,781	110,892	5.37	125,833	13.01	0.0110
2020-05-11	2020-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,174,781	110,892		125,833		11,050.6711
2020-02-06	2019-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,063,889	215,503	11.66	111,347	15.23	0.0076
2019-11-14	2019-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,848,386	-715,579	-27.91	96,634	-21.98	0.0072
2019-08-14	2019-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,563,965	330,584	14.80	123,865	9.78	0.0092
2019-05-15	2019-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,233,381	266,720	13.56	112,830	-3.22	0.0088
2019-02-12	2018-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,966,661	73,355	3.87	116,584	-6.46	0.0106
2018-11-09	2018-09-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,893,306	-76,497	-3.88	124,639	25.33	0.0096
2018-08-14	2018-06-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,969,803	239,684	13.85	99,451	9.18	0.0083
2018-05-15	2018-03-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,730,119	233,328	15.59	91,089	30.96	0.0077
2018-02-14	2017-12-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,496,791	82,220	5.81	69,557	21.56	0.0056
2017-11-14	2017-09-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,414,571	38,984	2.83	57,219	22.66	0.0049
2017-08-14	2017-06-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,375,587	-76,885	-5.29	46,647	10.59	0.0041
2017-05-15	2017-03-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,452,472	213,500	17.23	42,180	3.67	0.0038
2017-02-09	2016-12-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,238,972	-310,366	-20.03	40,687	-16.72	0.0038
2017-01-13	2016-09-30	13F/A-1	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,549,338	473,462	44.01	48,854	61.51	0.0049
2016-11-14	2016-09-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,549,338			48,854
2016-08-12	2016-06-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,075,876	-23,726	-2.16	30,249	-24.32	0.0032
2016-05-20	2016-03-31	13F/A-1	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,099,602	208,084	23.34	39,969	12.06	0.0043
2016-05-12	2016-03-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,099,602			39,969
2016-02-16	2015-12-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	891,518	-457,237	-33.90	35,668	-7.17	0.0039
2015-11-16	2015-09-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,348,755	-86,079	-6.00	38,422	-18.73	0.0045
2015-08-13	2015-06-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,434,834	63,703	4.65	47,277	19.90	0.0051
2015-05-15	2015-03-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,371,131	278,885	25.53	39,429	32.57	0.0040
2015-02-11	2014-12-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,092,246	-60,411	-5.24	29,741	21.08	0.0030
2014-11-12	2014-09-30	13F/A-1	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,152,657	-66,414	-5.45	24,564	-10.27	0.0026
2014-11-10	2014-09-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,152,657			24,564
2014-08-12	2014-06-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,219,071	-36,497	-2.91	27,375	-13.72	0.0030
2014-05-15	2014-03-31	13F/A-1	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,255,568	423,849	50.96	31,729	65.96	0.0036
2014-05-13	2014-03-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	1,255,568			31,729
2014-02-06	2013-12-31	13F/A-1	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	831,719	-50,505	-5.72	19,119	13.76	0.0021
2014-02-06	2013-12-31	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	721,644			11,575
2013-11-12	2013-09-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	882,224	-88,178	-9.09	16,806	20.07	0.0021
2013-08-08	2013-06-30	13F	EMERGENT BIOSOLUTIONS	Common equity shares	29089Q105	970,402	970,402		13,997		0.0018

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.